AU2002365863A1 - The use of cck-8 for the preparation of a pharmaceutical composition against inflammatory disorders - Google Patents

The use of cck-8 for the preparation of a pharmaceutical composition against inflammatory disorders

Info

Publication number
AU2002365863A1
AU2002365863A1 AU2002365863A AU2002365863A AU2002365863A1 AU 2002365863 A1 AU2002365863 A1 AU 2002365863A1 AU 2002365863 A AU2002365863 A AU 2002365863A AU 2002365863 A AU2002365863 A AU 2002365863A AU 2002365863 A1 AU2002365863 A1 AU 2002365863A1
Authority
AU
Australia
Prior art keywords
cck
preparation
pharmaceutical composition
inflammatory disorders
composition against
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002365863A
Inventor
Thomas Lundeberg
Luigi Manni
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU2002365863A1 publication Critical patent/AU2002365863A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/2207—Gastrins; Cholecystokinins [CCK]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2002365863A 2001-12-03 2002-11-28 The use of cck-8 for the preparation of a pharmaceutical composition against inflammatory disorders Abandoned AU2002365863A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE0103987 2001-12-03
SE0103987-4 2001-12-03
PCT/SE2002/002197 WO2003047612A1 (en) 2001-12-03 2002-11-28 The use of cck-8 for the preparation of a pharmaceutical composition against inflammatory disorders

Publications (1)

Publication Number Publication Date
AU2002365863A1 true AU2002365863A1 (en) 2003-06-17

Family

ID=20286131

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002365863A Abandoned AU2002365863A1 (en) 2001-12-03 2002-11-28 The use of cck-8 for the preparation of a pharmaceutical composition against inflammatory disorders

Country Status (2)

Country Link
AU (1) AU2002365863A1 (en)
WO (1) WO2003047612A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1732592A1 (en) * 2004-02-24 2006-12-20 Wisconsin Alumni Research Foundation Use of neuropeptides for ligament healing
US7776815B2 (en) 2004-02-24 2010-08-17 Wisconsin Alumni Research Foundation Use of neuropeptides for ligament healing

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9901578D0 (en) * 1999-05-03 1999-05-03 Karolinska Innovations Ab New use of substance in PNS

Also Published As

Publication number Publication date
WO2003047612A1 (en) 2003-06-12

Similar Documents

Publication Publication Date Title
AU2002313236A1 (en) Medicinal compositions
HUP0401642A3 (en) Use of staurosporine derivatives for the preparation of pharmaceutical compositions
AU2002222118A1 (en) Pharmaceutical compositions for inhalation
IL157734A0 (en) Pharmaceutical compositions for the treatment of urogenital disorders
AU2002337803A1 (en) Sustained release pharmaceutical compositions
AU2002257582A1 (en) Pharmaceutical formulation
AU2002302147A1 (en) Pharmaceutical composition
AUPR602501A0 (en) Sustained release pharmaceutical composition
HUP0400850A3 (en) Oral pharmaceutical compositions
AU2002258221A1 (en) Medicinal composition
AU2002365093A1 (en) Therapeutic compositions
AUPR600601A0 (en) Therapeutic compositions
AU2002215114A1 (en) Pharmaceutical compositions for inhalation
IL160852A0 (en) Pharmaceutical compositions for the treatment of urinary disorders
AU2002244865A1 (en) Pharmaceutical composition of ibuprofen
AU2002365863A1 (en) The use of cck-8 for the preparation of a pharmaceutical composition against inflammatory disorders
AU2002354460A1 (en) Medicinal composition
HUP0200253A2 (en) Pharmaceutical compositions for combination therapy
AUPR529701A0 (en) Pharmaceutical composition
AU2003281197A1 (en) Liquid compositions for the oral administration of lorazepam
AU2002346223A1 (en) Medicinal compositions
AU2001289719A1 (en) Use of anellated dihydropyridines for the preparation of pharmaceutical compositions for the treatment of chronic pain
AU7445601A (en) Pharmaceutical composition for the treatment of multiple sclerosis
HUP0103049A3 (en) Use of fluexetine for preparation of pharmaceutical compositions
AU2002100921A4 (en) Pharmaceutical composition

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase